Consistent with a role of CRT in mediating immunogenicity of ICD, knockdown of CRT or defects in CRT exposure pathway abolishes the ability of dying cancer cells succumbing to anthracyclines to establish protective immunity in mice, while the provision of exogenous CRT confers immunogenicity of otherwise nonimmunogenic types of RCD. Here, CALR is linked to cancer.